Website: http://biosimilars-biologics.pharmaceuticalconferences.com/
Place
Baltimore, United States of America
Conference Date
Oct 26 - Oct 28, 2015
Submission Deadline
May 18, 2015
Venue
Subjects: Biosciences and Technologies;
Sponsorship:
Indexing:
OMICS Group International is organizing 4th International Conference and Exhibition on Biologics and Biosimilars during October 26-28, 2014 Baltimore, USA. OMICS International Organises 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. Biosimilars are a true imitation of biopharmaceutical products that are set to replace 70% of global chemical drugs over the next couple of decades on account of safety parameters. It is estimated that about 50% of the current UK market for biological medicines by spend may be subject to biosimilar competition by 2019. Biologics are biological medical products made or derived from the active drug substance of a living organism by of recombination DNA or Controlled gene expression methods. There are about 193 companies of Biologics and Biosimilars in USA with 35,000 entrepreneurs working on these topics. All over the world, there are more than 380 companies producing Biologics and Biosimilars and 55,000 industrialists doing their research work. The global Biosimilars market is expected to reach $19.4 billion by 2014, growing at an Annual Growth Rate (CAGR) of 89.1% from 2009. By 2020, the global market for Biosimilars will be reaching $55 Billion. Biologic agents will continue to outpace overall pharma spending growth and are expected to represent 19-20% of the total market value by 2017. USA is leading its position in Biologics production and sales followed by European countries. Uptake of Biosimilars is more in European countries followed by China.
E-mail: biosimilars@conferenceseries.net
Tel: +1-888-843-8169
Rank: ★★★★
Online Proceedings:
Indexing Proof: View